Company: FCRS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110990
Chunk: 100

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 2
Chunk 100
---
,000 was placed in the Trust Account.

We paid a total of $17,861,874, consisting of
$5,000,000 of cash underwriting fee, $12,250,000 of deferred underwriting fee, and $611,874 of other offering costs.

For a description of the use of the proceeds generated
in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

Purchases of Equity
Securities by the Issuer and Affiliated Purchasers

None.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

Trading Arrangements

During the quarterly period
ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act)
adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each
term is defined in Item 408(a) of Regulation S-K.

21

Item 6. Exhibits

The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.

    No.
     
    Description of Exhibit

    1.1
     
    Underwriting Agreement, dated September 25, 2025, by and between the Company and the Representative, as representative of the several underwriters.
  
    3.1
     
    Amended and Restated Memorandum and Articles of Association of the Company.
  
    4.1
     
    Warrant Agreement, dated September 25, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
  
    10.1
     
    Investment Management Trust Agreement, September 25, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.
  
    10.2
     
    Registration Rights Agreement, dated September 25, 2025, by and among the Company and certain security holders.
  
    10.3
     
    Sponsor Private Placement Warrants Purchase Agreement, dated September 25, 2025, by and between the Company and the Sponsor.
  
    10.4
     
    Representative Private Placement Warrants Purchase Agreement, dated